Wednesday, November 17, 2021

CMS final rule officially delays best price requirement for drugmakersCMS final rule officially delays best price requirement for drugmakersCMS final rule officially delays best price requirement for drugmakers

CMS final rule officially delays best price requirement for drugmakers

U.S. territories will have until April 1, 2022 to decide whether or not to join the Medicaid Drug Rebate Program.



from Section Page News - Modern Healthcare https://ift.tt/2Z1ToKc

No comments:

Post a Comment